pharma news

News

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Possible implications of TrumpRx, the federal direct-to-consumer sales channel, are starting to emerge ahead of its scheduled launch next year.

News

Close up in sepia on Benjamin Franklin face on cash note

Soufflé's tasty $200m raise, and other biofinancings

New biotech financings include nine-figure rounds for Soufflé, Expedition, Arthrosi, and Nilo Therapeutics, with NanoPhoria and TORL not far behind.

News

In monster MASH takeover deal, Novo buys Akero for $4.7bn

Novo Nordisk has agreed to buy Akero and its MASH drug efruxifermin for $4.7bn upfront, soon after Wegovy was approved for the common liver disease.

News

Pharmacist shelving medicine in pharmacy

NHS could pay more for medicines under new plan

Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.

News

Woman collects medicine bottle from vending kiosk

Amazon to launch drug vending machines at One Medical sites

Amazon's latest bid to disrupt the healthcare market in the US will see the introduction later this year of electronic drug dispensing kiosks.

News

Regeneron's Libtayo stakes out new territory in skin cancer

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for cutaneous squamous cell carcinoma.

TrumpRx, BlinkRX, GoodRx – what's going on in DTC sales?

Soufflé's tasty $200m raise, and other biofinancings

In monster MASH takeover deal, Novo buys Akero for $4.7bn

NHS could pay more for medicines under new plan

Amazon to launch drug vending machines at One Medical sites

Regeneron's Libtayo stakes out new territory in skin cancer

Gilead strikes again, penning $5bn deal to buy Tubulis

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks